KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma Meeting Abstract
| Authors: | Uppaluri, R.; Lee, N. Y.; Westra, W.; Cohen, E. E. W.; Haddad, R. I.; Temam, S.; Le Tourneau, C.; Chernock, R.; Safina, S.; Klochikhin, A.; Meirovitz, A.; Brana, I.; Ge, J. Y.; Swaby, R. F.; Bidadi, B.; Adkins, D. |
| Abstract Title: | KEYNOTE-689: Phase 3 study of adjuvant and neoadjuvant pembrolizumab combined with standard of care (SOC) in patients with resectable, locally advanced head and neck squamous cell carcinoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 364s |
| Language: | English |
| ACCESSION: | WOS:000487345803408 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS6090 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS6090 -- Source: Wos |
